Systematic review on oral antibacterial relay therapy for acute staphylococcal prosthetic joint infections treated with debridement, antibiotics and implant retention (DAIR)
Journal of Antimicrobial Chemotherapy · 2024
DOI: 10.1093/jac/dkae347 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2024. Verfasst von Benoit Gachet und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biostatistics, ULR 2694 METRICS Evaluation des technologies de santé et des pratiques médicales, Gustave Dron Hospital of Tourcoing, Li…. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Debridement, Prosthesis-Related Infections, Staphylococcal Infections. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 30 Literaturangaben.
Abstract (Originalsprache)
Background
The management of acute prosthetic joint infections (PJIs) often involves a debridement, antibiotics and implant retention (DAIR) strategy.
Objective
Our objective was to conduct a systematic review and a network meta-analysis (NMA) to assess the comparative effectiveness of available oral antimicrobial regimens for the treatment of acute staphylococcal PJIs treated with DAIR.
Methods
We conducted a systematic review searching articles from databases creation until 31 December 2023. We included articles on acute staphylococcal PJIs managed with DAIR with an oral antibiotic regimen relaying the initial management. The primary outcome was the remission rate.
Results
Out of the 2421 studies screened, six studies completed the systematic review criteria: one randomized controlled trial and five observational studies. There was heterogeneity in patients’ populations, duration and posology of treatments, definition of outcome and length of follow-up. Studies revealed 10 antibiotic regimens and most data focusing on five combinations recommended by the IDSA's guidelines: rifampicin associated to fluoroquinolone, clindamycin, cycline, linezolid or trimethoprim-sulfamethoxazole. Treatment comparisons were often secondary, without adjustment for confounding factors, resulting in a high risk of bias. Owing to inconsistencies a complete analysis, including an NMA was not possible.
Conclusion
The available data highlight five companions to rifampicin, however, there is insufficient evidence to compare them. The literature does not provide a basis for rationalizing alternatives when rifampicin cannot be used.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biostatistics, ULR 2694 METRICS Evaluation des technologies de santé et des pratiques médicales, Gustave Dron Hospital of Tourcoing, Lille University, Lille, France.
- Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, AP-HP, Hôpital Pitié-Salpêtrière, Département de Santé Publique, 75013 Paris, France.
- INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, UMR-S 1136, AP-HP, Paris, France.
ORCID-Profile: Eric Senneville, Olivier Robineau
Zitieren
APA
Gachet, B., Dechartres, A., Senneville, E., & Robineau, O. (2024). Systematic review on oral antibacterial relay therapy for acute staphylococcal prosthetic joint infections treated with debridement, antibiotics and implant retention (DAIR). Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkae347
Vancouver
Gachet B, Dechartres A, Senneville E, Robineau O. Systematic review on oral antibacterial relay therapy for acute staphylococcal prosthetic joint infections treated with debridement, antibiotics and implant retention (DAIR). Journal of Antimicrobial Chemotherapy. 2024. doi:10.1093/jac/dkae347
BibTeX
@article{Gachet2024,
author = {Gachet, Benoit and Dechartres, Agnès and Senneville, Eric and Robineau, Olivier},
title = {Systematic review on oral antibacterial relay therapy for acute staphylococcal prosthetic joint infections treated with debridement, antibiotics and implant retention (DAIR)},
journal = {Journal of Antimicrobial Chemotherapy},
year = {2024},
doi = {10.1093/jac/dkae347}
}
EUVIMED